Volume 78, Pages S33-S36 (August 2010)

Slides:

Advertisements

Similar presentations

Volume 67, Pages S1-S7 (June 2005)

Advertisements

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Propofol-related green urine

Anemia management in chronic kidney disease

Volume 83, Issue 3, Pages (March 2013)

Volume 64, Pages S72-S77 (November 2003)

The risk of hospitalization and modality failure with home dialysis

Progression of renal failure and hypertensive nephrosclerosis

Volume 63, Pages S88-S90 (June 2003)

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Volume 78, Pages S41-S45 (August 2010)

Volume 70, Pages S21-S25 (December 2006)

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Malnutrition and inflammation in peritoneal dialysis patients

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Lipid redistribution in renal dysfunction

Severe exfoliative skin rash with icodextrin

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Nephrology Crosswords: Hemodialysis

Volume 86, Issue 2, Pages (August 2014)

The epidemiology of chronic kidney disease

Use of vitamin D in chronic kidney disease patients

Volume 87, Issue 2, Pages (February 2015)

Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.

U-shaped effect of eGFR and mortality

The calcium–phosphorus in guidelines for CKD-MBD

Volume 70, Issue 12, Pages (December 2006)

Nephrology Crossword: History of nephrology

Kenar D. Jhaveri, Steven Fishbane Kidney International

Prescribing and monitoring hemodialysis dose

Volume 73, Issue 12, Pages (June 2008)

Volume 74, Pages S88-S93 (December 2008)

Role of vitamin D receptor activators on cardiovascular risk

Recent experience with high-dose intravenous iron administration

Volume 56, Pages S31-S37 (December 1999)

A physician's perseverance uncovers problems in a key nephrology study

Volume 64, Pages S72-S77 (November 2003)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Nephrology Crossword: Peritoneal Dialysis

Atrial fibrillation in end-stage renal disease: an emerging problem

Extracorporeal removal of toxins

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival.

Volume 80, Issue 3, Pages (August 2011)

A man with a hole in his penis

Prehypertension: is it relevant for nephrologists?

Volume 73, Issue 9, Pages (May 2008)

Volume 82, Issue 9, Pages (November 2012)

The treatment of acute interstitial nephritis: More data at last

Volume 79, Issue 5, Pages (March 2011)

Volume 63, Pages S79-S82 (June 2003)

Clinical benefits of slowing the progression of renal failure

Organ transplantation goes to the movies

Volume 55, Pages S3-S16 (June 1999)

Volume 83, Issue 4, Pages (April 2013)

Charles A. Herzog Kidney International

Volume 70, Issue 3, Pages (August 2006)

Volume 75, Issue 7, Pages (April 2009)

Miguel G. Salom, Bárbara Bonacasa Kidney International

The international realities of live donor kidney transplantation

Increased fetuin-A levels following treatment with a vitamin D analog

Volume 55, Pages S41-S46 (June 1999)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Presentation transcript:

Volume 78, Pages S33-S36 (August 2010) Treatment of secondary hyperparathyroidism in ESRD: a 2-year, single-center crossover study Neal Mittman, Brinda Desiraju, Kevin B. Meyer, Jyoti Chattopadhyay, Morrell M. Avram Kidney International Volume 78, Pages S33-S36 (August 2010) DOI: 10.1038/ki.2010.191 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Episodes of hypercalcemia, hyperphosphatemia, and elevated Ca × P (calcium–phosphorus product) during calcitriol and paricalcitol treatment (adjusting for equivalent doses). Kidney International 2010 78, S33-S36DOI: (10.1038/ki.2010.191) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 All-cause missed doses during 12 months of calcitriol and paricalcitol treatment (P<0.0001). Kidney International 2010 78, S33-S36DOI: (10.1038/ki.2010.191) Copyright © 2010 International Society of Nephrology Terms and Conditions